Telegram RegisterThe public register of Telegram
Telegram profile photo for Pharma collections

Channel

Pharma collections

@medicationstudent7

On this record: Topic · Also posting the same content · Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

3,037subscribers

+19 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of 1,000–3,162.

Register entry

Telegram ID-1001578065294
TypeChannel
Username@medicationstudent7
CreatedBetween 1 August 2021 and 28 February 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded7 August 2026
Last confirmed live19 September 2026
Measurements held13
Confirmed unchanged1 time, most recently 19 September 2026
On Telegramt.me/medicationstudent7

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 14 September 2026 and assigned it the closest of 31 fixed categories, at 77% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Also posting the same content

This channel’s posts match, word for word or near enough, posts on 3 other registered channels, found by comparing text fingerprints across every channel on the register. That matching has been checked by hand against the live Telegram pages and found reliable — 0 wrong of 45 pairs re-read.

Which channel, if either, published first is deliberately not shown. The same hand-check found that reading wrong 18 of 45 times — 60%, no better than a coin flip — because it depends on how deep our own crawl happened to reach into each channel’s history, not on when the content was actually first posted. This list is ordered by subscriber count, the same as every other listing on this site, never by which channel we think came first. Word-for-word matching has several ordinary explanations besides copying — a channel mirroring itself, an unattributed repost, or two channels independently repeating the same wire story — and this measurement cannot tell those apart. How this is measured.

Growth

3,0143,0503,0327 August 2026 — 3,018 subscribers7 August 2026 — 3,018 subscribers12 August 2026 — 3,014 subscribers16 August 2026 — 3,024 subscribers20 August 2026 — 3,021 subscribers23 August 2026 — 3,018 subscribers26 August 2026 — 3,020 subscribers30 August 2026 — 3,033 subscribers1 September 2026 — 3,050 subscribers6 September 2026 — 3,045 subscribers11 September 2026 — 3,041 subscribers14 September 2026 — 3,039 subscribers19 September 2026 — 3,037 subscribers3,0377 August 202619 September 2026
13 measurements spanning 43 days, net +19. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 3,009–3,055 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
19 Sept 2026, 09:393,037-2
14 Sept 2026, 20:363,039-2
11 Sept 2026, 09:013,041-4
6 Sept 2026, 23:173,045-5
1 Sept 2026, 23:543,050+17
30 Aug 2026, 03:343,033+13
26 Aug 2026, 18:573,020+2
23 Aug 2026, 20:583,018-3
20 Aug 2026, 00:263,021-3
16 Aug 2026, 14:223,024+10
12 Aug 2026, 19:433,014-4
7 Aug 2026, 11:533,018no change
7 Aug 2026, 05:453,018first reading

Engagement

21 posts held, back to 18 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 3 pages of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 21 posts for this entry, the most recent from 7 August 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

13 reactions across 8 posts, in 2 distinct kinds. The most used accounts for 84.6% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
❤1184.6%
👍215.4%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 8 of the 21 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 13 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 21 most recent posts we hold, published 18 July 2026 to 7 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

3 Aug 2026, 19:09 UTC119 views2 reactionsread 8 August 2026
Forwarded from @Clinical_Notes

Posted without readable text

❤2

Signed Rezg AL_ Sunah

3 Aug 2026, 19:09 UTC101 viewsread 8 August 2026
Forwarded from @Clinical_Notes

📌 5: عقار Pivmecillinam 💊التحديث: اعتماد Pivmecillinam (النموذج الأولي الفموي لـ Mecillinam) لعلاج التهابات المسالك البولية غير المعقدة. ● الميزة: يتميز ببنية كيميائية تجعله ركيزة ضعيفة لغالبية إنزيمات β-lactamase (بما فيها ESBL وبعض إنزيمات OXA-48 و NDM). ● الجرعة السريرية الموصى بها: 370 ملجم فموياً كل 8 ساعات (والتي تختلف عن الجرعة المدونة في النشرة المعتمدة) لتحقيق فاعلية سريرية ممتازة وتجنب الفشل العلاجي. #Cli…

Signed Rezg AL_ Sunah

3 Aug 2026, 19:09 UTC81 viewsread 8 August 2026
Forwarded from @Clinical_NotesPhoto

🆕🆕🆕 إطلاق تحديث IDSA 2026 لعلاج البكتيريا سالبة الجرام المقاومة للمضادات الحيوية 🩺ESBL, AmpC, CRE, DTR P. aeruginosa, CRAB, و S. maltophilia. أهم الركائز: التأكيد على أهمية الفحص الجزيئي لآليات المقاومة (سواء إنزيمات Serine أو Metallo-β-lactamases) لتوجيه الاختيار الدوائي الدقيق بدلاً من الاعتماد التخميني. #Clinical_Notes #IDSA

Signed Rezg AL_ Sunah

3 Aug 2026, 19:09 UTC76 viewsread 8 August 2026
Forwarded from @Clinical_Notes

📌 2: مضاد Gepotidacin- فئة جديدة لعلاج uUTI 💀 التحديث: Gepotidacin هو أول مضاد حيوي من فئة Triazaacenaphthylene يقر للاستخدام السريري. ● آلية العمل: يثبط تضاعف الحمض النووي البكتيري عبر مواقع ارتباط فريدة على إنزيماتو Topoisomerase IV، مما يعني عدم تأثره بالطفرات التي تسبب المقاومة للفينولكينات (مثل Ciprofloxacin). ● الاستخدام الموصى به: خيار مفضل لعلاج التهابات المسالك البولية غير المعقدة (uUTI) الناجمة عن البكت…

Signed Rezg AL_ Sunah

3 Aug 2026, 19:09 UTC78 viewsread 8 August 2026
Forwarded from @Clinical_Notes

📌 3: الفوسفوميسين الوريدي (IV Fosfomycin) 💉التحديث: الموافقة الرسمية على التركيبة الوريدية من Fosfomycin لعلاج التهابات المسالك المعقدة (cUTI). ● المكانة السريرية: يُعد خياراً بديلاً لعلاج cUTI الناجمة عن E. coli المنتجة لـ ESBL أو CRE. ● تنبيه مهم للجرعة والسلامة: يحتوي الفوسفوميسين الوريدي على كمية عالية جداً من الصوديوم تتجاوز الحد اليومي الموصى به، مما يتطلب حذراً شديداً عند استخدامه لكبار السن أو مرضى قص…

Signed Rezg AL_ Sunah

3 Aug 2026, 19:09 UTC95 viewsread 8 August 2026
Forwarded from @Clinical_Notes

📌 4: عقار Sulopenem etzadroxil-probenecid 💊 التحديث: أول مضاد حيوي فموي من عائلة Thiopenem يُعتمد لعلاج التهابات المسالك البولية. ● الاستخدام: يُوصى به كخيار مفضل لعلاج uUTI الناجم عن ESBL-E، وكخيار بديل للانتقال إلى العلاج الفموي (Oral step-down) في حالات cUTI بعد تحقيق استجابة سريرية بالحقن الوريدي. ● الآلية: أُضيف إليه مركب Probenecid لتقليل الإطراح الكلوي وزيادة تركيز الدواء في الدم، ولكن يجب الحذر من التداخلا…

Signed Rezg AL_ Sunah

31 Jul 2026, 23:36 UTC174 views1 reactionsread 8 August 2026

🔴 التقاء الذكاء البشري مع الذكاء الاصطناعي نتج عنه دواء يؤخذ بالفم لانقاص الوزن بديلا للحقن‼️وحصل على تصريح الFDA في أبريل ٢٠٢٦. الدواء اسمه فاوندايو Foundayo ويعد نقلة نوعية في عالم علاج السمنة بأدوية تؤخذ بالفم. في مشهد علمي تاريخي، لم يكتفِ العقل البشري بمواهبه الطبيعية، بل سخّر الذكاء الاصطناعي لتحليل ملايين الجزيئات افتراضياً، فكان الولادة الفعلية لأول دواء من فئة GLP-1 ولكن non-peptide و بالتالي يمكن تناوله…

❤1

Signed Rezg AL_sunah

31 Jul 2026, 13:31 UTC188 views2 reactionsread 8 August 2026

ACE inhibitors are the first-line therapy for reducing proteinuria in patients with proteinuric kidney disease. They decrease proteinuria by approximately 30–50% by dilating the efferent arteriole, lowering intraglomerular pressure, and reducing glomerular protein filtration, while also providing long-term renoprotective benefits. In contrast, tacrolimus, a calcineurin inhibitor, exerts a more potent direct anti-pr…

❤2

Signed Dr.Edreess Aidan

30 Jul 2026, 18:37 UTC192 viewsread 8 August 2026

Which of the following medications has the most potent direct anti-proteinuric effect in nephrotic syndrome? A. Empagliflozin B. Spironolactone C. Tacrolimus D. ACE inhibitors E. Rituximab

Signed Dr.Edreess Aidan

30 Jul 2026, 16:53 UTC425 views1 reactionsread 8 August 2026
Photo

🔴 How to Administer Vancomycin in Hospital من أكثر المضادات الحيوية التي تحتاج دقة عالية في الجرعة، التحضير، وسرعة الإعطاء هو Vancomycin، لأن أي خطأ في route, dose, infusion rate, or monitoring قد يؤثر على فعالية العلاج أو يزيد من خطر السمية، خصوصًا nephrotoxicity و vancomycin infusion reaction. في هذا الإنفوجرافك تم تلخيص أهم النقاط العملية بشكل مبسط ومرتب، وتشمل: 🔹 اختيار الطريق الصحيح: IV للعدوى الجهازية و Oral …

❤1

Signed Rezg AL_ Sunah

28 Jul 2026, 14:54 UTC254 viewsread 8 August 2026
Photo

نتيجة استخدام دواء diclofenac عن طريق الوريد

Signed Dr.Edreess Aidan

Showing the 12 most recent of 21 posts we hold for @medicationstudent7. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 2 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

"لعلي أفيدك" Clinical discussion
@l3lee_afeedk · 26,629
Telegram ranks this channel #9 of 67 here — alongside 66 others — read 12 September 2026
👑 مملكة الطب | Kingdom of Medicine 💊
@Systemic7Medicine · 38,979
Telegram ranks this channel #60 of 87 here — alongside 86 others — read 31 August 2026

This channel appears in 2 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 19 September 2026 — this entry's latest reading, not the date you are reading this.

“Pharma collections” (@medicationstudent7), 3,037 subscribers as measured 19 September 2026. Telegram Register, tgregister.com/channel/medicationstudent7.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.